Cencora (NYSE:COR) Issues FY 2026 Earnings Guidance

Cencora (NYSE:COR) updated its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 17.700-17.900 for the period, compared to the consensus earnings per share estimate of 17.760. The company issued revenue guidance of -.

Cencora Price Performance

Shares of NYSE:COR opened at $284.94 on Thursday. Cencora has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The firm has a fifty day moving average price of $282.09 and a 200 day moving average price of $322.80. The firm has a market cap of $55.44 billion, a price-to-earnings ratio of 21.85, a P/E/G ratio of 1.52 and a beta of 0.59.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter in the prior year, the firm posted $4.42 earnings per share. Cencora’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, sell-side analysts expect that Cencora will post 17.79 earnings per share for the current fiscal year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s dividend payout ratio is presently 18.40%.

Cencora declared that its board has approved a stock buyback plan on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 22nd. Bank of America upped their price objective on Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research report on Wednesday. William Blair initiated coverage on Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating for the company. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Finally, Wells Fargo & Company decreased their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cencora has a consensus rating of “Moderate Buy” and an average target price of $367.75.

Insider Buying and Selling at Cencora

In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the purchase, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. The trade was a 14.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.38% of the company’s stock.

Institutional Trading of Cencora

Several institutional investors and hedge funds have recently made changes to their positions in the business. Kemnay Advisory Services Inc. bought a new position in shares of Cencora in the fourth quarter worth about $25,000. Motiv8 Investments LLC bought a new stake in Cencora during the 4th quarter valued at about $29,000. Turning Point Benefit Group Inc. bought a new stake in Cencora during the 3rd quarter valued at about $74,000. DV Equities LLC purchased a new stake in Cencora in the 4th quarter valued at about $91,000. Finally, Greenline Wealth Management LLC purchased a new stake in Cencora in the 4th quarter valued at about $109,000. 97.52% of the stock is currently owned by institutional investors.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.